1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Rossari Biotech Limited

Rossari Biotech Limited

ROSSARI.BO
Rossari Biotech LimitedIN flagBombay Stock Exchange
529.65
INR
-15.40
- -
29.34BMarket Cap
Rossari Biotech Limited
ROSSARI.BO
(Bombay Stock Exchange)

Recent

price

529.65

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
60.21
106.02
123.03
137.19
268.96
299.62
330.59
376.16
432.82
385.71
Revenue per Share
5.25
9.44
13.42
15.56
17.81
19.46
23.67
24.66
26.95
24.41
Basic EPS, GAAP
2.41
5.62
-3.94
-2
-1.62
21.53
-15.94
-3.81
-36.05
- -
Free Cash Flow per Basic Share
0.05
2.19
0.54
0.49
0.5
0.5
0.5
0.5
0.5
- -
Dividend per Share
14.77
22.36
35.18
48.31
62.5
81.21
104.25
128.07
2
- -
Book Value per Share
17.98
24.35
57.98
76.68
99.3
116.22
142.16
170.09
200.38
- -
Tangible Book Value per Share
48
48
49
52
55
55
55
55
55
55
Basic Weighted Avg Shares
2,914
5,131
5,982
7,074
14,752
16,513
18,252
20,803
23,964
21,344
Sales/Revenue/Turnover
12.89
12.79
14.73
14.17
8.82
9.18
10.01
9.52
8.63
9.3
Operating Margin (%)
52
123
169
228
481
629
604
671
791
694
Depreciation Expense
254
457
653
802
977
1,073
1,307
1,364
1,492
1,351
Net Income, GAAP
32.21
27.94
25.71
25.08
28.31
25.63
26.42
26.36
26.32
26.71
Effective Tax Rate (%)
8.72
8.9
10.91
11.34
6.62
6.5
7.16
6.56
6.23
6.33
Profit Margin (%)
367
380
1,776
2,045
3,146
3,717
4,188
5,054
4,463
- -
Working Capital
13
7
340
- -
- -
349
442
1,223
1,146
- -
LT Debt
871
1,238
2,867
4,088
8,052
9,152
10,477
11,854
13,333
- -
Total Equity
- -
39.57
26.78
19.52
15.11
12.39
12.41
11.31
9.56
- -
Return on Invested Capital (%)
- -
46.55
38.72
33.93
35.56
28.38
23.84
18.45
24.79
107.53
Return on Capital (%)
- -
50.85
46.73
38.18
33
27.14
25.55
21.25
41.49
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
957
- -
LT Borrowings
- -
1,000
- -
LT Finance Leases
- -
223
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
55
- -
Market Capitalization
42,814
33,406
38,154

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
10,419
- -
Cash, Cash Equivalents & STI
- -
1,165
- -
Accounts Receivable, Net
- -
4,745
- -
Inventories
- -
3,551
- -
Total Current Liabilities
- -
5,366
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
957
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
30.15%
12.48%
Free Cash Flow
- -
-171.08%
847.38%
Net Income, GAAP
- -
13.44%
9.41%
Sales/Revenue/Turnover
- -
32.03%
15.19%
Total Cash Common Dividend
- -
- -
0.11%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,106
4,835
4,638
4,673
18,252
2025
4,896
4,984
5,127
5,796
20,803
2026
5,437
5,817
6,849
- -
23,964

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5.3
5.97
6.23
- -
23.67
2025
6.32
6.39
5.73
6.22
24.66
2026
6.07
5.92
8.3
- -
26.95

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.5
2025
- -
- -
- -
- -
0.5
2026
- -
- -
- -
- -
0.5
Similar Companies
Tessenderlo Group N.V. (TESB.BR)
It-chem (309710.KQ)
Nan Pao Resins Chemical Co., Ltd. (4766.TW)
Juheshun Advanced Material Co., Ltd. (605166.SS)
The Chemours Company (0HWG.L)
NOROO Holdings Co., Ltd. (000320.KS)
Business
Rossari Biotech Limited manufactures and markets specialty chemicals, enzymes, and biotech solutions primarily for the textile, animal health and nutrition, home and personal care, and performance chemicals sectors. The company offers a diversified portfolio including textile specialty chemicals such as enzymes and products for pre-treatment, dyeing, printing, and finishing; animal health products encompassing poultry feed supplements, additives, vitamin premixes, enzymes, acidifiers, trace minerals, essential oils, and pet-care solutions; home and personal care formulations featuring laundry and cleaning enhancers; and performance chemicals like polymers for detergents, emulsions for paints and paper, ceramics strengtheners, and water treatment agents. Rossari Biotech Limited operates manufacturing facilities in India, including sites in Dahej, Silvassa, and through subsidiaries, with a primary focus on the Indian market and emerging global expansion; founded in 2003 as Rossari Labtech and incorporated in 2009, the company maintains headquarters in Mumbai, Maharashtra. Recent developments include capacity expansions such as an additional 20,000 MTPA at its Dahej facility, 15,000 MTPA ethoxylation at Unitop Chemicals (Phase 1), and further enhancements at Tristar Intermediates and Unitop totaling over 50,000 MTPA; acquisitions of Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, Romakk Chemicals Private Limited, and Lozalo International for pet-care; land purchases adjoining Dahej for Rs 15 crore and in Gujarat for Rs 9 crore by subsidiaries; and approval of up to USD 8 million investment in a wholly-owned subsidiary in Saudi Arabia to bolster international presence.